Talking Tachlis Podcast
Talking Tachlis Podcast - interview with Dr. Phillip Schwartz
0 Comments
February has seen the news full of stories of virus mutations, increased vaccinations and global inequality. Volume 5 looks at these headlines and more. Global Pandemic
Industry News
Financial News
With January nearing a close, Volume 4 looks at how the pandemic is progressing and whether vaccinations are starting to roll out. Global Pandemic
Industry News
Financial News
As we enter 2021 Volume 3 reviews Emergency Use Authorization approvals as the world scrambles to vaccinate as quickly as possible. Pandemic 2021
Industry News
Financial News
Volume 2 of our Industry Updates sees the second Covid-19 wave still raging and highlights the latest vaccine developments. Pandemic Stats Update Second COVID-19 Wave Still Raging
Industry News Pfizer/BioNTech Vaccine Rollout/Allergic Reactions
Moderna Approval
Astra Zeneca/Sputnik Discussions
CSL/University of Queensland’s Protein Sub-Unit Based Vaccine Cancelled
Sanofi/GSK Delayed
Johnson & Johnson (J&J) One-Shot Adenovirus Vaccine Now up to 45,000 Stage 3 Trial Participants
Valneva Whole Inactivated Virus (WIV) Vaccine Enters Trials
Finance News Novavax Executives Sell Shares
Gates Provides Funding for Second Wave Covid-19 Vaccines
Welcome to our first Industry Update, which brings you the latest news in Covid-19 Vaccine Developments and Industry Financial Updates. Covid-19 Vaccine Developments
Industry Financial Valuation Updates
|